Bayer's Mirena Gets FDA Approval for Extended Use as Contraceptive
18 Agosto 2022 - 8:18AM
Noticias Dow Jones
By Cristina Roca
Bayer AG said Thursday that the U.S. Food and Drug
Administration has approved its Mirena device for extended use as a
contraceptive.
The German pharmaceutical and chemicals company said its
supplemental new drug application for use of up to eight years in
the contraception indication was approved by the regulator.
Mirena is a hormonal intrauterine system.
Its duration of use remains unchanged at up to five years for
its second approved indication in the U.S.
Write to Cristina Roca at cristina.roca@wsj.com
(END) Dow Jones Newswires
August 18, 2022 09:03 ET (13:03 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bayer (TG:BAYN)
Gráfica de Acción Histórica
De May 2023 a May 2024